ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,298.00
0.34%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,292.46
-1.12%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Aclaris Therapeutics Inc (ACRS)

  7. Aclaris Therapeutics Inc (ACRS) 뉴스

ACRS Aclaris Therapeutics Inc

1.20
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Aclaris Therapeutics Inc ACRS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 1.20 17:00:00
개장가 저가 고가 종가 전일 종가
1.20
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202421:00PRNUSFlare Therapeutics Appoints Douglas Manion, M.D., FRCP (C)..
06/03/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202421:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202421:14EDGAR2Form 8-K - Current report
27/02/202421:00GLOBEAclaris Therapeutics Reports Fourth Quarter and Full Year..
15/02/202410:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202404:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202404:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202409:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:31EDGAR2Form 8-K/A - Current report: [Amend]
06/02/202406:30EDGAR2Form 8-K - Current report
19/01/202421:30EDGAR2Form 8-K - Current report
16/01/202421:00GLOBEAclaris Therapeutics Announces Leadership Changes and..
10/01/202421:00GLOBEAclaris Therapeutics Announces Top-line Results from 4-Week..
04/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:15EDGAR2Form 8-K - Current report
20/12/202306:01GLOBEAclaris Therapeutics Provides Corporate Update
06/12/202306:01GLOBEAclaris Therapeutics Announces Patent License Agreement with..
13/11/202321:42EDGAR2Form 8-K - Current report
13/11/202321:00GLOBEAclaris Therapeutics Announces Top-line Results from 12-Week..
06/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202321:15EDGAR2Form 8-K - Current report
06/11/202321:00GLOBEAclaris Therapeutics Reports Third Quarter 2023 Financial..
26/10/202305:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202305:06EDGAR2Form 144 - Report of proposed sale of securities
03/10/202320:00GLOBEAclaris Therapeutics Completes Enrollment in Phase 2b Study..
20/09/202320:00GLOBEAclaris Therapeutics to Participate in the 2023 Cantor..
18/09/202321:00EDGAR2Form 8-K - Current report
18/09/202320:00GLOBEAclaris Therapeutics Announces Positive Results from Phase 1..
08/09/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202305:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:20EDGAR2Form 144 - Report of proposed sale of securities
07/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202320:15EDGAR2Form 8-K - Current report
07/08/202320:00GLOBEAclaris Therapeutics Reports Second Quarter 2023 Financial..
04/08/202305:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/06/202320:01GLOBEAclaris Therapeutics Completes Enrollment in Phase 2b Study..
02/06/202320:00GLOBEAclaris Therapeutics to Participate in Two June Healthcare..
08/05/202320:00GLOBEAclaris Therapeutics Reports First Quarter 2023 Financial..
02/05/202320:01GLOBEAclaris Therapeutics to Announce First Quarter 2023..

최근 히스토리

NASDAQ
ACRS
Aclaris Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유